ISSN 1301 - 0883 / E-ISSN 1309 - 3886
 
 








  An Experimental Study That Investigate Effects of Atreleuton in Metabolic Syndrome [Eastern J Med]
Eastern J Med. 2021; 26(2): 280-285 | DOI: 10.5505/ejm.2021.65477  

An Experimental Study That Investigate Effects of Atreleuton in Metabolic Syndrome

Tevfik Noyan, Sertaç Burhanettin Ayhan
Department of Biochemistry, Ordu University Medical Faculty, Ordu.

INTRODUCTION: The inflammation, LDL oxidation, and insulin resistance play an important role in the development of metabolic syndrome (MetS). This study aims to investigate the effects of atreleuton on serum lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), leukotriene B4 (LTB-4), insulin, and adipose tissue glucose transporter 4 (GLUT-4) levels in an experimental MetS model in rats.
METHODS: The rats were randomly divided into 3 groups: Group 1 (control, n = 7); Group 2 (MetS group, n = 8), Group 3 (MetS + atreleuton administered group, atreleuton (25 mg/kg/day) was administrated orally by gavage during the last 4 weeks of the experiment). MetS was created by feeding rats with high fructose and fat diet for 10 weeks in groups 2 and 3. Measurements of test parameters were made by ELISA method.
RESULTS: The atreleuton caused a significant decrease in levels of serum LTB-4, LOX-1, insulin, and homeostatic model assessment for insulin resistance (HOMA-IR), while significantly increase on quantitative insulin sensitivity check index (QUICKI). However, atreleuton did not cause a significant change in tissue GLUT-4 level.
DISCUSSION AND CONCLUSION: The results of this study suggest that atrelutone may be a protective agent against MetS complications by decreasing the levels of LTB-4 and LOX-1 that play an important role in MetS pathogenesis. Besides, the effect of atreleuton on the tissue GLUT-4 pathway needs to be supported by further studies.

Keywords: Atreleuton, GLUT-4, insulin resistance, LOX-1, LTB-4, metabolic syndrome


Tevfik Noyan, Sertaç Burhanettin Ayhan. An Experimental Study That Investigate Effects of Atreleuton in Metabolic Syndrome. Eastern J Med. 2021; 26(2): 280-285

Corresponding Author: Tevfik Noyan, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Copyright © 2021 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale